Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial

By afschroeder • July 11, 2026

Grinspoon SK, DeFilippi C, Umbleja T, McCallum S, Christenson RH, Chu SM, Lu AB, Burdo TH, Aberg JA, Fichtenbaum CJ, Bloomfield GS, Malvestutto CD, Currier JS, Lu MT, Zanni MV, Douglas PS, Ribaudo HJ. Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial. JACC Adv. 2026 Jul 10;5(8):102984. doi: 10.1016/j.jacadv.2026.102984. Epub ahead of print. PMID: 42431097.

Tags: Biomarker, cardiovascular disease, HIV, Infectious Diseases, inflammatory, lipid, Publications, Statins

Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings

Smith OA, Merritt S, Kompany JP, Hoff NA, Wong TAS, Kamara V, Tambu M, Halbrook M, Kindrachuk J, Barrall AL, Musene K, Martin SA, Berestecky[...]

Virus reactivation in acute and long COVID-19

Maguire C, Chen J, Rouphael N, Morse BA, Hoch A, Pickering H, Phan HV, Glascock A, Chu V, Dandekar R; IMPACC Network; Corry D, Kheradmand[...]

Variation in Hospital Visiting Hour Policies in Acute Care Facilities in Four U.S. States: An Exploratory Cross-Sectional Analysis

Garcia CY, Chou C, Caso E, Hudspeth JC, Allan-Blitz LT. Variation in Hospital Visiting Hour Policies in Acute Care Facilities in Four U.S. States: An[...]